← United States · Coverage record
US · SEC FORM 4
Medpace Holdings, Inc.
MEDP · Nasdaq · CIK 0001668397 · Healthcare · Diagnostics & Research
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
50 Form 4 transaction lines observed in the same window
32 sales · 18 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-02-27 · EWALD STEPHEN P.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 1,596,293
- Previous report
- 1,685,597
- Avg daily volume
- 275,442
- Days to cover
- 5.8
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2025-02-27 | EWALD STEPHEN P | Purchase (P) | Common Stock | 2 | USD 326.11 | USD 652 | SEC filing ↗ |
| 2022-09-22 | Troendle August J. | Purchase (P) | Common Stock | 57,426 | USD 154.59 | USD 8,877,485 | SEC filing ↗ |
| 2022-09-22 | Medpace Investors, LLC | Purchase (P) | Common Stock | 57,426 | USD 154.59 | USD 8,877,485 | SEC filing ↗ |
| 2022-09-21 | Troendle August J. | Purchase (P) | Common Stock | 94,119 | USD 161.63 | USD 15,212,454 | SEC filing ↗ |
| 2022-09-21 | Medpace Investors, LLC | Purchase (P) | Common Stock | 94,119 | USD 161.63 | USD 15,212,454 | SEC filing ↗ |
| 2022-09-20 | Troendle August J. | Purchase (P) | Common Stock | 94,119 | USD 155.14 | USD 14,601,622 | SEC filing ↗ |
| 2022-09-20 | Medpace Investors, LLC | Purchase (P) | Common Stock | 94,119 | USD 155.14 | USD 14,601,622 | SEC filing ↗ |
| 2022-09-19 | Troendle August J. | Purchase (P) | Common Stock | 94,119 | USD 153.48 | USD 14,445,384 | SEC filing ↗ |
| 2022-09-19 | Medpace Investors, LLC | Purchase (P) | Common Stock | 94,119 | USD 153.48 | USD 14,445,384 | SEC filing ↗ |
| 2022-09-16 | Troendle August J. | Purchase (P) | Common Stock | 62,516 | USD 149.58 | USD 9,351,143 | SEC filing ↗ |
| 2022-09-16 | Medpace Investors, LLC | Purchase (P) | Common Stock | 62,516 | USD 149.58 | USD 9,351,143 | SEC filing ↗ |
| 2022-09-15 | Troendle August J. | Purchase (P) | Common Stock | 62,516 | USD 153.11 | USD 9,571,825 | SEC filing ↗ |
| 2022-09-15 | Medpace Investors, LLC | Purchase (P) | Common Stock | 62,516 | USD 153.11 | USD 9,571,825 | SEC filing ↗ |
| 2022-09-14 | Troendle August J. | Purchase (P) | Common Stock | 62,516 | USD 152.66 | USD 9,543,693 | SEC filing ↗ |
| 2022-09-14 | Medpace Investors, LLC | Purchase (P) | Common Stock | 62,516 | USD 152.66 | USD 9,543,693 | SEC filing ↗ |
Form 4 evidence
93 transaction lines in the latest 365-day window; 645 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | BURWIG SUSAN E | Option exercise / conversion (M) | Common Stock | 3,000 | USD 166.73 | USD 500,190 | SEC filing ↗ |
| 2026-10-07 | BURWIG SUSAN E | Option exercise / conversion (M) | Common Stock | 2,000 | USD 166.73 | USD 333,460 | SEC filing ↗ |
| 2026-09-30 | McCarthy Cornelius P. III | Option exercise / conversion (M) | Common Stock | 28 | USD — | USD — | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | BURWIG SUSAN E | Option exercise / conversion (M) | Common Stock | 3,000 | USD 166.73 | USD 500,190 | SEC filing ↗ |
| 2026-10-07 | BURWIG SUSAN E | Option exercise / conversion (M) | Common Stock | 2,000 | USD 166.73 | USD 333,460 | SEC filing ↗ |
| 2026-09-30 | McCarthy Cornelius P. III | Option exercise / conversion (M) | Common Stock | 28 | USD — | USD — | SEC filing ↗ |
| 2026-09-30 | Kraft Robert O. | Option exercise / conversion (M) | Common Stock | 32 | USD — | USD — | SEC filing ↗ |
| 2026-09-30 | Carley Brian T | Option exercise / conversion (M) | Common Stock | 36 | USD — | USD — | SEC filing ↗ |
| 2026-09-30 | Troendle August J. | Sale (S) | Common Stock | 21,966 | USD 625.47 | USD 13,739,074 | SEC filing ↗ |
| 2026-09-29 | Troendle August J. | Sale (S) | Common Stock | 26,701 | USD 621.02 | USD 16,581,855 | SEC filing ↗ |
| 2026-09-28 | Troendle August J. | Sale (S) | Common Stock | 2,410 | USD 620.07 | USD 1,494,369 | SEC filing ↗ |
| 2026-09-25 | Troendle August J. | Sale (S) | Common Stock | 154 | USD 620.60 | USD 95,572 | SEC filing ↗ |
| 2026-09-24 | Troendle August J. | Sale (S) | Common Stock | 27,833 | USD 621.33 | USD 17,293,478 | SEC filing ↗ |
| 2026-09-23 | Troendle August J. | Sale (S) | Common Stock | 16,083 | USD 628.64 | USD 10,110,417 | SEC filing ↗ |
| 2026-09-22 | Troendle August J. | Sale (S) | Common Stock | 49,018 | USD 628.11 | USD 30,788,696 | SEC filing ↗ |
| 2026-09-21 | Troendle August J. | Sale (S) | Common Stock | 21,883 | USD 623.29 | USD 13,639,455 | SEC filing ↗ |
| 2026-09-17 | Troendle August J. | Sale (S) | Common Stock | 10,880 | USD 620.40 | USD 6,749,952 | SEC filing ↗ |
| 2026-09-16 | Troendle August J. | Sale (S) | Common Stock | 8,770 | USD 621.29 | USD 5,448,713 | SEC filing ↗ |
| 2026-09-15 | Troendle August J. | Sale (S) | Common Stock | 15,971 | USD 620.84 | USD 9,915,436 | SEC filing ↗ |
| 2026-09-15 | BURWIG SUSAN E | Option exercise / conversion (M) | Common Stock | 3,000 | USD 166.73 | USD 500,190 | SEC filing ↗ |
| 2026-08-27 | Troendle August J. | Sale (S) | Common Stock | 650 | USD 620.27 | USD 403,176 | SEC filing ↗ |
| 2026-08-26 | Kraft Robert O. | Sale (S) | Common Stock | 3,858 | USD 617.81 | USD 2,383,511 | SEC filing ↗ |
| 2026-08-26 | Kraft Robert O. | Option exercise / conversion (M) | Common Stock | 3,858 | USD 84.36 | USD 325,461 | SEC filing ↗ |
| 2026-08-26 | Troendle August J. | Sale (S) | Common Stock | 4,000 | USD 620.03 | USD 2,480,120 | SEC filing ↗ |
| 2026-08-25 | Troendle August J. | Sale (S) | Common Stock | 673 | USD 620.38 | USD 417,516 | SEC filing ↗ |
| 2026-08-24 | Troendle August J. | Sale (S) | Common Stock | 1,983 | USD 620.23 | USD 1,229,916 | SEC filing ↗ |
| 2026-08-21 | Troendle August J. | Sale (S) | Common Stock | 13,995 | USD 624.45 | USD 8,739,178 | SEC filing ↗ |
| 2026-08-20 | Brady Kevin M. | Sale (S) | Common Stock | 3,400 | USD 625.24 | USD 2,125,816 | SEC filing ↗ |
| 2026-08-20 | Brady Kevin M. | Option exercise / conversion (M) | Common Stock | 3,400 | USD 138.87 | USD 472,158 | SEC filing ↗ |
| 2026-08-20 | Troendle August J. | Sale (S) | Common Stock | 27,174 | USD 618.79 | USD 16,814,999 | SEC filing ↗ |
| 2026-08-19 | Troendle August J. | Sale (S) | Common Stock | 15,609 | USD 606.47 | USD 9,466,390 | SEC filing ↗ |
| 2026-08-19 | DAVENPORT FRED B JR | Sale (S) | Common Stock | 7,283 | USD 606.15 | USD 4,414,590 | SEC filing ↗ |
| 2026-08-19 | DAVENPORT FRED B JR | Option exercise / conversion (M) | Common Stock | 7,583 | USD 116.08 | USD 880,262 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | MEDP |
| CIK | 0001668397 |
| Sector | Healthcare |
| Industry | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8731 Services-Commercial Physical & Biological Research |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 645 transaction lines from 2020-01-31 to 2026-10-12 36 P purchase lines · 452 S sale lines · 157 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.